Discover
CAI
Caris Life Sciences, Inc.
23.23
5 x 23.22
3 x 23.24
bid
ask
-
0.16
0.71%
01:34 PM
timesize
| Ytd | -13.88% | |
| 1y | -23.09% |
23.00
day range
23.66
14.19
52 week range
42.50
| Open | 23.39 | Prev Close | 23.40 | Low | 23.00 | High | 23.66 | Mkt Cap | 6.57B |
| Vol | 2.20M | Avg Vol | 3.65M | EPS | 0.36 | P/E | 65.28 | Forward P/E | 64.26 |
| Beta | 0.68 | Short Ratio | 3.52 | Inst. Own | 57.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 17.29 | 200-d Avg | 21.28 | 1yr Est | 26.75 |
| Income Statement | |||
| Total Revenue | 263.71M | ||
| Revenues (USD) | 263.71M | ||
| Cost of Revenue | 84.12M | ||
| Gross Profit | 179.60M | ||
| Operating Expenses | 177.80M | ||
| Research and Development Expense | 32.36M | ||
| Selling, General and Administrative Expense | 120.31M | ||
| Operating Income | 1.80M | ||
| Interest Expense | 9.23M | ||
| Income Tax Expense | 23.00K | ||
| Net Income | -637.00K | ||
| Net Income Common Stock | -637.00K | ||
| Net Income Common Stock (USD) | -637.00K | ||
| Consolidated Income | -637.00K | ||
| Earning Before Interest & Taxes (EBIT) | 8.61M | ||
| Earning Before Interest & Taxes (USD) | 8.61M | ||
| Weighted Average Shares | 282.89M | ||
| Weighted Average Shares Diluted | 282.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 690.92M | ||
| Cash and Equivalents (USD) | 690.92M | ||
| Investments | 102.20M | ||
| Investments Current | 102.20M | ||
| Trade and Non-Trade Receivables | 116.89M | ||
| Current Assets | 1.06B | ||
| Property, Plant & Equipment Net | 95.72M | ||
| Total Assets | 1.23B | ||
| Debt Current | 178.00K | ||
| Total Debt | 393.15M | ||
| Current Liabilities | 191.44M | ||
| Debt Non-Current | 392.97M | ||
| Total Liabilities | 637.89M | ||
| Accumulated Retained Earnings (Deficit) | -2.55B | ||
| Accumulated Other Comprehensive Income | 529.00K | ||
| Shareholders Equity | 591.73M | ||
| Shareholders Equity (USD) | 591.73M | ||
| Assets Non-Current | 171.79M | ||
| Total Debt (USD) | 393.15M | ||
| Goodwill and Intangible Assets | 19.34M | ||
| Inventory | 123.79M | ||
| Liabilities Non-Current | 446.45M | ||
| Trade and Non-Trade Payables | 85.99M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.98M | ||
| Net Cash Flow from Financing | -36.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -130.65M | ||
| Capital Expenditure | -22.07M | ||
| Issuance (Purchase) of Equity Shares | -17.68M | ||
| Issuance (Repayment) of Debt Securities | -13.96M | ||
| Net Cash Flow from Investing | -122.19M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -100.12M | ||
| Net Cash Flow from Operations | 28.48M | ||
| Effect of Exchange Rate Changes on Cash | -27.00K | ||
| Share Based Compensation | 22.22M | ||